Zdrowie i gospodarka · 02/04/2012

FDA Corrects Notice on Biosimilar Product Draft Guidances and Public Hearing

The Food and Drug Administration (FDA) is correcting a notice regarding a public hearing and request for comments on draft guidances for biosimilar products, which was published with an incorrect submission deadline. The FDA is seeking input on the recently issued draft guidances.